Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.655    0.005 (0.11%)
Bid:
4.61
Ask:
4.68
Spread: 0.07 (1.518%)
Market Cap: £223.42m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Directorate Changes

3 Jan 2012 07:00

RNS Number : 8382U
Seeing Machines Limited
03 January 2012
 



 

3 January 2012

Seeing Machines Limited

 

("Seeing Machines" or the "Company")

 

Directorate Changes

 

Seeing Machines Limited (AIM: SEE), a leading developer of facial image processing software for applications that rely on understanding the movement of human faces and eyes, announces today the appointment of Kenneth (Ken) Kroeger to the board of Seeing Machines as Managing Director and the resignation of past Chairman William (Bill) Mobbs as a director of the Company. Mr Mobbs resignation takes effect from the 31st of December 2011 and Mr Kroeger's appointment is with immediate effect.

 

Bill Mobbs who joined the board of the Company in 2006 and took over as Chairman in 2009 leaves the board to concentrate on his other business interests.

 

Ken Kroeger, aged 50, is a successful technology entrepreneur who founded Catalyst Interactive, an internationally recognised 3-D simulation and training provider (later acquired by KBR). At Catalyst Interactive, Ken grew the organisation from inception to an international business through technical innovation and sound leadership.

 

Ken's background in technology, research and development, business management and sales has provided Seeing Machines with a strong commercial focus since his appointment as CEO in July 2011.

 

David Gaul, the current Chairman of the Company commented:

 

"The Company is delighted that Ken has joined the board and the directors are already aware that he brings a wealth of industry knowledge and experience which will prove invaluable to Seeing Machines. The Company wishes to express its sincere thanks to Bill Mobbs for his significant contribution to the Company over the last 5 years."

 

Save for the above, the following information, pursuant to AIM Rule 17, Schedule Two (g) is disclosed in respect of the appointment of Ken:

 

Current Appointments:

Travelok Pty LtdHealthcube Management Pty LtdHealthcube Pty LtdKroeger Nominees Pty LtdLighthouse Business Innovation Centre LimitedConnexions Pty LtdContact Action Pty LtdInsperience Pty Ltd

Past Appointments:

Catalyst Interactive Pty LtdEqual Access Testing Pty Ltd

Mr Kroeger is not currently interested in the total issued share capital of the Company.

 

 

 

 

Enquiries:

 

Seeing Machines Limited

Ken Kroeger, Managing Director & CEO

+61 (0) 2 6103 4700

 

Daniel Stewart & Company plc(Nomad & Broker)

David Hart/James Thomas

+44 (0) 20 7776 6550

 

Walbrook PR Ltd

+44 (0) 20 7933 8780

Bob Huxford

bob.huxford@walbrookpr.com

Helen Westaway

helen.westaway@walbrookpr.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUMAGUPPGUP
Date   Source Headline
6th Jul 20069:12 amRNSDirector/PDMR Shareholding
29th Jun 20069:37 amRNSEmployee Share Option Scheme
27th Jun 200610:11 amRNSGrant of US Patent
5th Jun 200610:14 amRNSHolding(s) in Company
10th May 20069:27 amRNSHolding(s) in Company
13th Apr 20063:25 pmRNSDirector/PDMR Shareholding
13th Apr 200612:47 pmRNSNew faceLAB Camera Product
10th Apr 20069:19 amRNSMajor Industry Awards Win
15th Mar 20067:01 amRNSInterim Results
3rd Mar 20069:42 amRNSAGM Statement-Amendment
28th Feb 20069:15 amRNSAGM Statement
8th Feb 20069:25 amRNSHolding(s) in Company
31st Jan 20069:30 amRNSHolding(s) in Company
25th Jan 20069:24 amRNSHolding(s) in Company
10th Jan 20069:18 amRNS1st Glaucoma Trial Completion
20th Dec 20053:46 pmRNSIssue of Equity
6th Dec 20059:41 amRNSHolding(s) in Company
1st Dec 20058:53 amRNSAdmission to AIM-Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.